NIDA Research Monograph, Number 92 [Printed in 1989]
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph92.pdf - Testing for Abuse Liability of Drugs in Humans (2.2 MB)
Table of Contents
Introduction
Testing and Abuse Liability of Drugs in Humans-----1
Charles R. Schuster
The Necessity and Utility of Abuse Liability Evaluations in Human Subjects: The FDA Perspective-----7
Frank J. Vocci, Jr
The Role of Abuse Liability Testing in Drug Control Procedures-----21
Howard McClain, Jr. and Frank Sapienza
Historical Perspectives on the Use of Subjective Effects Measures in Assessing the Abuse Potential of Drugs-----43
Jerome H. Jaffe and Faith K. Jaffe
Drug Identification and Classification
Human Abuse Liability Assessment by Measurement of Subjective and Physiological Effects-----73
Donald R. Jasinski and Jack E. Henningfield
Drug Discrimination: Methods for Drug Characterization and Classification-----101
George E. Bigelow and Kenzie L. Preston
Assessment of the Reinforcing Properties
Abuse Liability of Anxiolytics and Sedative/Hypnotics: Methods Assessing the Likelihood of Abuse-----123
John D. Roache and Roland R. Griffiths
Drug Self-Administration Procedures: Alcohol and Marijuana-----147
Nancy K. Mello
The Use of Choice Procedures for Assessing the Reinforcing Properties of Drugs in Humans-----171
Chris E. Johanson and Harriet de Wit
Relationship Between Self-Reported Drug Effects and Their Reinforcing Effects: Studies with Stimulant Drugs-----211
Marian W. Fischman
Epidemiologic Assessment of Drug Abuse of Drugs
Case Reports and the Assessment of Drug Abuse Liability-----231
Edward C. Senay
United States Epidemiologic Data on Drug Use and Abuse: How are They Relevant to Testing Abuse Liability of Drugs?-----241
James C. Anthony and Alison M. Trinkoff
Current Approaches to Measurements of Drug Use and Abuse in Sweden-----267
Ulf Bergman and David Lee
Evaluation of the Abuse Liability of Drugs in Humans: Issues and Future Directions
Pharmacokinetic and Phartnacodynamic Drug Interactions: Implications for Abuse Liability Testing-----287
Edward M. Sellers, Usanda Busto, and Howard L. Kaplan
Promising New Biologic and Behavioral Correlates of the Reinforcing Properties of Drugs-----307
Jack H. Mendelson, Nancy K. Mello, Scott E. Lukas, Bryan T. Woods, and Siew K. Teoh
Drug Abuse Liability Testing: Human Subject Issues-----341
Herbert D. Kleber
Issues in Human Drug Abuse Liability Testing: Overview and Prospects for the Future-----357
Joseph V. Brady
Conference Summary and Perspectives on Human Drug Abuse Liability Testing-----371
Mary Jeanne Kreek
Index-----377
List of NIDA Research Monographs-----393
|